Samsung is moving forward with a steady rollout of blood pressure measurement and ECG monitoring on its consumer smartwatches. After securing regulatory approvals and launching the features in South Korea and the U.S. last year, the tech company announced today that both health monitoring tools will soon be released in an additional 31 countries.
The expansion follows the Samsung Health Monitor...
Price transparency and direct-payment insurance startup Sidecar Health has announced a $125 million Series C round led by Drive Capital. New investors BOND, Tiger Global and Menlo Ventures, as well as prior backers Cathay Innovations and GreatPoint Ventures, also participated.
This raise is a substantial jump in size from its $20 million round back in July or its $18 million raise from 2019. With...
Apple has fleshed out its recently launched Fitness+ subscription offering with celebrity-driven audio content that encourages Apple Watch owners to take their device for regular strolls.
Called "Time to Walk," the new feature downloads weekly episodes that range from 25 to 40 minutes in length and play through paired Bluetooth headphones.
These sessions feature musicians, athletes and other...
Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021.
Bardy's flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. It's a P-wave signal-capturing wearable...
Preventice Solutions, the maker of various wearable cardiac sensors for remote patient monitoring, is set to be acquired by medical technology firm Boston Scientific for $925 million, with as much as $300 million in potential commercial milestones on the table as well.
Due to Boston Scientific's existing 22% equity stake in Preventice, those price tags translate to $720 million and a potential $...
Consumer telehealth and wellness brand Hims & Hers wrapped up its merger with special purpose acquisition company (SPAC) Oaktree Acquisition Tuesday, and today began trading on the New York Stock Exchange.
The deal was first announced in October, and was originally expected to close before the end of its Q4 2020. After Tuesday's approval, the deal has provided Hims with $279.5 million, $205...
Israeli continuous remote patient-monitoring company Biobeat is taking its business beyond the hospital with the launch of a home-based version of its technology.
The new offering comes in the form of a take-home kit consisting of a wireless photoplethysmography (PPG) vitals monitor, adhesives used to place the monitor on the patient's chest and an instruction manual. It also includes iOS and...
K Health, a startup combining a free symptom checker with text-based telehealth and virtual primary care, has announced $132 million Series E – its third major raise within the course of a year.
GGV Capital, Valor Equity Partners and Kaiser Permanente pension fund headlined the raise, with GGV Managing Partner Hans Tung and Valor founder and CEO Antonio Gracias joining K Health's board. Other...
For all of the weight healthcare disruptors throw behind the idea of innovation, there's something to be said about moving too fast and breaking too many things. Adoption of new digital tools should never lead to an interruption in patients' care.
COVID-19, however, wasn't the type of disruption that health systems had on their calendars. A shift away from in-person visits and a skyrocketing...
AI-enabled diagnostic and treatment platform Paige (formerly Paige.AI) has announced a $100 million Series C round led by Casdin Capital and Johnson & Johnson Innovation. The startup's prior backers and other unnamed funds also took part in the raise.
Paige uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at a lower...
